Pancytopenia in a Young Dog After NSAID Exposure
A 2-year-old female intact Labrador Retriever presents with 3 days of lethargy, fever (40.1 C), and petechiae on the gingiva. The owner reports giving an unknown dose of an over-the-counter NSAID for limping 10 days ago. CBC: WBC 1.4 x10^9/L (ref 6-17), segmented neutrophils 0.6 x10^9/L, platelets 18 x10^9/L, HCT 0.28 L/L (ref 0.37-0.55), reticulocytes 15 x10^9/L (ref <60). Blood smear shows no platelet clumps, moderate toxic change in the few neutrophils present, and rare metarubricytes. Serum biochemistry is unremarkable except mild hypoalbuminemia. The clinician asks whether this is an immune-mediated process and whether to start steroids immediately.
1. How do you interpret the combination of neutropenia, thrombocytopenia, and non-regenerative anemia, and what is your top differential versus immune-mediated destruction?
Read the worked answer
The triad of neutropenia, thrombocytopenia, and non-regenerative anemia with toxic neutrophilic change points first to bone marrow suppression/injury, not peripheral immune destruction. Key discriminators:
- Immune-mediated thrombocytopenia (IMTP) typically produces isolated thrombocytopenia with a regenerative marrow response and often large/giant platelets; concurrent severe neutropenia and non-regenerative anemia are atypical unless Evans syndrome, which would still usually show regeneration once bleeding occurs.
- Estrogen toxicity or drug-induced myelosuppression (NSAIDs, chemotherapy, phenylbutazone-type drugs) fits the pancytopenia with toxic change and lack of regeneration.
- Infectious marrow disease (ehrlichiosis, parvovirus in a young dog, FeLV not applicable) must be excluded.
The non-regenerative anemia is the strongest argument against pure immune destruction: with 10 days of bleeding (petechiae) you would expect a reticulocytosis if the marrow could respond. Absent that, the marrow is the problem.
Conclusion: favor drug/toxin-induced or infectious myelosuppression over IMTP; do not commit to steroids on CBC alone.
2. What diagnostic step do you recommend before committing to immunosuppressive therapy, and what specific findings would change your management?
Read the worked answer
Recommendation: bone marrow aspirate (and core biopsy if aspirate is hypocellular or dry tap) before starting steroids.
Rationale:
- If the marrow is hypocellular/aplastic with fat replacement, this supports toxin/estrogen/infectious suppression - steroids are not indicated and could worsen infection risk.
- If the marrow is hypercellular with adequate megakaryocytes and the peripheral destruction is the issue, IMTP becomes more likely and immunosuppression is appropriate.
- If marrow shows neoplasia (e.g., lymphoma, leukemia) or organisms, management diverges entirely.
Additional tests to run concurrently: tick-borne disease PCR/serology (Ehrlichia, Anaplasma), parvovirus antigen/PCR, and a careful drug history including estrogen-containing compounds or prior NSAID dosing.
Findings that would change management:
- Hypocellular marrow → stop NSAID, supportive care, consider colony-stimulating factors, avoid steroids.
- Hypercellular marrow with megakaryocytic hyperplasia → treat as IMTP with steroids ± second agent.
- Organisms on smear → targeted antimicrobials.
If the dog deteriorates (febrile neutropenia, sepsis) before marrow results, supportive care and broad-spectrum antibiotics take priority over immunosuppression.